Form 4: Thermo Fisher CFO Reports Routine Stock Disposition

Thermo Fisher Scientific's Sr. VP and CFO, Stephen Williamson, reported the disposition of common stock shares to cover tax obligations.

Summary

• Stephen Williamson, Sr. VP and CFO of Thermo Fisher Scientific Inc., reported transactions involving the company's common stock.
• On August 28, 2025, a total of 783.273 shares of common stock were disposed of at a price of $489.74 per share.
• These dispositions were made to satisfy tax withholding obligations, indicated by transaction code "F".
• Following these transactions, Mr. Williamson directly beneficially owns 32,320.193 shares of common stock.
• Additionally, 12,674 shares are indirectly beneficially owned through a SLAT, with beneficial ownership disclaimed except for pecuniary interest.

Sentiment

Score: 5

Explanation: The transaction is a routine disposition of shares to cover tax obligations, which is a neutral event and does not indicate a positive or negative sentiment towards the company's prospects.

Future Outlook

NA

Industry Context

This filing is a routine insider transaction report and does not provide broader industry context or trends. It reflects an individual executive's stock activity rather than a company-wide strategic move.

Related Party Transactions

• 12,674 shares are indirectly beneficially owned through a SLAT, with the reporting person disclaiming beneficial ownership except to the extent of any pecuniary interest.

Stakeholder Impact

• The disposition of a relatively small number of shares by a senior executive for tax purposes is a routine event and is unlikely to have a material impact on shareholders, employees, customers, suppliers, or creditors.

Key Dates

Recommendation

This Form 4 filing details a routine disposition of shares by a senior executive to cover tax obligations, which is a common and expected event. It does not provide new information that would fundamentally alter the investment thesis for Thermo Fisher Scientific, nor does it signal any significant change in management's confidence or the company's operational performance. Therefore, a 'hold' recommendation is appropriate as the filing itself does not warrant a change in investment position.

Keywords

Thermo Fisher Scientific, TMO, Stephen Williamson, Insider Transaction, Form 4, Stock Disposition, CFO, Tax Withholding